Catalent (CTLT) Reports Q3 Loss, Misses Revenue Estimates
CTLTCatalent(CTLT) Zacks Investment Research·2024-05-09 08:31

Catalent (CTLT) came out with a quarterly loss of 0.06pershareversustheZacksConsensusEstimateof0.06 per share versus the Zacks Consensus Estimate of 0.24. This compares to loss of 0.09pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−1250.09 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -125%. A quarter ago, it was expected that this maker of drug delivery technologies would post a loss of 0.03 per share when it actually produced a loss of $0.24, delivering a surprise of -700%. Over the last four quarters, the company h ...